Montelukast Sodium Ip
Montelukast sodium chewable tablets are a leukotriene receptor antagonist indicated for: • Prophylaxis and chronic treatment of asthma in patients 2 years of age and older ( 1.1 ).
United States
$2
per month
India
$0
per month
You save
−78%save $2/mo · 78% cheaper
12.5M US scripts/yr$20.2M potential annual savings$25.8M US spend/yr
Drag to rotate · 3D structureC35H36ClNO3S
SMILES: CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O
Compare the price
US price$2per month
India price$0per month
You save$278% less
Based on 30 EAs per month. US $0.07 vs India $0.02 per EA.
Total over 1 periodSave $2$2 → $0
The bigger picture
Montelukast Sodium Ip is filled about 12.5M times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$25.8M
If sourced from India
$5.6M
Potential annual savings
$20.2M
−78%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.